Managing diabetes often involves ongoing expenses for blood sugar monitoring equipment and testing supplies. Fortunately, Medicare provides coverage for eligible beneficiaries, helping reduce the cost of traditional glucose meters and continuous glucose monitoring systems. Understanding which devices are covered, who qualifies, and how much beneficiaries must pay can make it easier to access essential diabetes management tools.
What Medicare Covers for Glucose Monitoring
Medicare Part B treats blood glucose monitors as durable medical equipment (DME), meaning the program can pay for the device itself along with the supplies needed to use it regularly (source). This coverage is not limited to the monitor alone. Related items such as test strips, lancets, lancet holders, and blood sugar control solutions are also included when a doctor or other qualified health care provider orders them for use at home (source).
In addition to traditional blood glucose monitors, Medicare also covers continuous glucose monitors (CGMs) and their associated supplies, including sensors. A CGM tracks glucose levels automatically throughout the day and night, removing the need for frequent finger-stick testing. For many people managing diabetes, this technology represents a meaningful improvement in daily quality of life, and Medicare’s coverage of these devices has expanded considerably in recent years (source).
Who Qualifies for Medicare Glucose Monitor Coverage
Eligibility for a traditional blood glucose monitor under Medicare Part B requires a doctor or qualified health care provider to order the device as medically necessary for home use (source). The ordering provider and the durable medical equipment supplier must both be enrolled in Medicare for the coverage to apply.
For CGMs specifically, eligibility rules were updated in April 2023 following a major policy change from the Centers for Medicare and Medicaid Services. Anyone with diabetes who uses insulin in any form or amount now qualifies for CGM coverage, which eliminated a previous restriction that required a specific daily insulin dosage (source). This change opened CGM access to a much broader group of Medicare beneficiaries who rely on insulin therapy.
The 2023 update also created a pathway to CGM coverage for people with diabetes who do not take insulin at all. Those individuals may qualify if they have a documented history of problematic hypoglycemia, defined as recurrent level 2 hypoglycemic events or at least one level 3 hypoglycemic event (source). Hypoglycemia at these levels presents serious health risks, and a CGM can alert users before blood sugar drops to a dangerous point.
Medicare also requires that within the six months before a CGM is ordered, a treating practitioner must conduct an in-person visit or a Medicare-approved telehealth appointment with the beneficiary to evaluate how well diabetes is being managed (source). Additionally, the beneficiary must demonstrate sufficient training to operate the device correctly before coverage begins (source).
How Much Beneficiaries Pay Out of Pocket
Once a Medicare beneficiary meets the Part B deductible for the year, the standard cost-sharing arrangement applies: the beneficiary pays 20 percent of the Medicare-approved amount for the device and supplies, provided the supplier accepts assignment (source). The same cost structure applies to CGMs and their associated sensor supplies (source).
Choosing a supplier that accepts Medicare assignment is an important step. Suppliers who accept assignment agree to charge only the Medicare-approved amount, which protects beneficiaries from higher out-of-pocket costs that could result from working with a non-participating supplier.
Choosing a Device Under Medicare’s Coverage Rules
Medicare does not restrict CGM coverage to a single brand or product line. Any FDA-approved CGM device qualifies for coverage, giving beneficiaries and their health care providers flexibility in selecting the device that best fits the individual’s lifestyle and medical needs (source). However, the ordering provider must evaluate the beneficiary before placing the order and confirm that eligibility conditions are met (source).
Both the ordering physician and the durable medical equipment supplier must hold active Medicare enrollment for the coverage to be processed successfully. Beneficiaries should verify supplier enrollment status before finalizing any equipment arrangements to avoid unexpected billing complications.
Learn More About Medicare-Covered Glucose Monitors
Medicare’s coverage for glucose monitors, including both traditional devices and continuous glucose monitors, provides meaningful financial relief for people managing diabetes. Eligibility expanded significantly in 2023, allowing more beneficiaries to access CGM technology than ever before.
Understanding the qualification criteria, cost-sharing structure, and device options available through Medicare Part B empowers beneficiaries to make well-informed decisions alongside their health care providers. Anyone who uses insulin or has experienced serious hypoglycemic events may now have access to monitoring tools that were previously out of reach under Medicare’s earlier, more restrictive rules.